EFFECT OF CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS ON BLOOD-PRESSURE CONTROL

被引:65
作者
SALDANHA, LF
WEILER, EWJ
GONICK, HC
机构
[1] CEDARS SINAI MED CTR,DEPT MED,TRACE ELEMENT LAB,HALPER BLDG,ROOM 124,8700 BEVERLY BLVD,LOS ANGELES,CA 90048
[2] UNIV CALIF LOS ANGELES,SCH MED,LOS ANGELES,CA 90024
关键词
CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIALYSIS; BLOOD PRESSURE;
D O I
10.1016/S0272-6386(12)81091-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
To assess the efficacy of blood pressure control in continuous ambulatory peritoneal dialysis (CAPD), blood pressure was examined sequentially in 63 CAPO patients transferred from hemodialysis (HD), and in 97 patients started de novo on CAPd (NEW), over periods ranging from 3 to 63 months. Blood pressure changes were related to changes in body weight, hematocrit, and treatment with recombinant human erythropoietin (rHu-EPO), as well as to changes in antihypertensive drug requirements. Both groups of patients showed an immediate improvement in blood pressure control at 1 month, as manifested by an absolute decrease in blood pressure in HD patients (-4.3% ± 2.1% [SEM), P < 0.05) and by a decrease in antihypertensive drug requirements in NEW patients (from 78% to 43.3%). This early improvement in blood pressure appeared to be VOlume-related, as reflected by changes in body weight. Both groups showed an additional decrement in blood pressure at approximately 6 months (-7.8% ± 2.6% [SEM), P < 0.05, HD group; -3.4% ± 2.4% [SEM), P < 0.05, NEW group). Treatment of anemia with rHu-EPO in 22 of the CAPD patients had no effect on blood pressure. CAPD thus appears to be more effective than HD in controlling blood pressure. © 1993, National Kidney Foundation. All rights reserved. All rights reserved.
引用
收藏
页码:184 / 188
页数:5
相关论文
共 19 条
[1]   COMPARATIVE CARDIAC EFFECTS OF HEMODIALYSIS AND CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J].
ALPERT, MA ;
VANSTONE, J ;
TWARDOWSKI, ZJ ;
RUDER, MA ;
WHITING, RB ;
KELLY, DL ;
MADSEN, BR .
CLINICAL CARDIOLOGY, 1986, 9 (02) :52-60
[2]   CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS IN DIABETICS WITH END-STAGE RENAL-DISEASE [J].
AMAIR, P ;
KHANNA, R ;
LEIBEL, B ;
PIERRATOS, A ;
VAS, S ;
MEEMA, E ;
BLAIR, G ;
CHISOLM, L ;
VAS, M ;
ZINGG, W ;
DIGENIS, G ;
OREOPOULOS, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (11) :625-630
[3]   HYPERTENSION FOLLOWING ERYTHROPOIETIN THERAPY IN ANEMIC HEMODIALYSIS-PATIENTS [J].
BUCKNER, FS ;
ESCHBACH, JW ;
HALEY, NR ;
DAVIDSON, RC ;
ADAMSON, JW .
AMERICAN JOURNAL OF HYPERTENSION, 1990, 3 (12) :947-955
[4]  
Cambi V, 1987, Contrib Nephrol, V54, P218
[5]  
CANNATE JB, 1986, DIALYSIS TRANSPLANT, V15, P675
[6]  
CHAN MK, 1981, LANCET, V7, P1409
[7]  
GILMOUR J, 1985, PERITON DIALYSIS B, V5, P112
[8]  
GLASSON P, 1982, CLIN SCI, V63, P207
[9]  
KORZETS Z, 1989, ADV PERIT D, V5, P20
[10]  
KOYAMA H, 1989, LANCET, V1, P991